Literature DB >> 1987887

Rhabdomyolysis and simvastatin.

J P Deslypere, A Vermeulen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987887     DOI: 10.7326/0003-4819-114-4-342_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.

Authors:  M E Rubio-Gozalbo; D A van Waardenburg; P P Forget; L J Spaapen; A Verrips; P C Vroomen
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

2.  Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Authors:  Beatrice A Golomb; Abril Verden; Alexis K Messner; Hayley J Koslik; Keith B Hoffman
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

Review 3.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 4.  Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.

Authors:  G L Plosker; D McTavish
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

5.  A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients.

Authors:  J Contermans; J W Smit; P R Bär; D W Erkelens
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

6.  Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination.

Authors:  Anirban Nandy; Shahin Gaïni
Journal:  Case Rep Med       Date:  2016-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.